Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (181-190 of 825) with videos related to

Pageof 83
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Analysis of the B cell subpopulations influenced by allogeneic effect factor. I. MHC restricted enhancement of b cell responses to thymic-independent antigens, types 1 and 2, in normal and CBA/N miceL J Yaffe, J J Mond, A Ahmed, et al.
Cancer|February 1, 1993
Immune-mediated thrombocytopenia secondary to suraminA D Seidman, M Schwartz, L Reich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Antibodies against liposomes in normal and immune-defective miceB Banerji, J J Kenny, I Scher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
The asymmetry in idiotype-isotype expression in the response to phosphocholine is due to divergence in the expressed repertoires of Lyb-5+ and Lyb-5- B cellsL S Wicker, G Guelde, I Scher, et al.
The Journal of Experimental Medicine|November 1, 1980
Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defectH S Boswell, M I Nerenberg, I Scher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Regulation of T15 idiotype dominance. II. Genes unlinked to the Igh locus regulate T15 dominance of the secondary adoptive transfer response to phosphocholineL S Wicker, G Guelde, I Scher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
The immune response to a synthetic amino acid terpolymer in man: relationship to HL-A typeI Scher, A K Berning, D M Strong, et al.
Nature Reviews. Clinical Oncology|March 6, 2013
Validation and clinical utility of prostate cancer biomarkersHoward I Scher, Michael J Morris, Steven Larson, et al.
Cancer Treatment Reports|May 1, 1986
Phase II trial of N-methylformamide for advanced renal cell carcinomaC N Sternberg, A Yagoda, H I Scher, et al.
Urology|April 1, 1995
Distinguishing prognostic and treatment-predictive information for localized prostate cancerG Steineck, J Adolfsson, H I Scher, et al.
Pageof 83

Showing results (181-190 of 825) with videos related to

Sort By:
Pageof 83
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Analysis of the B cell subpopulations influenced by allogeneic effect factor. I. MHC restricted enhancement of b cell responses to thymic-independent antigens, types 1 and 2, in normal and CBA/N miceL J Yaffe, J J Mond, A Ahmed, et al.
Cancer|February 1, 1993
Immune-mediated thrombocytopenia secondary to suraminA D Seidman, M Schwartz, L Reich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Antibodies against liposomes in normal and immune-defective miceB Banerji, J J Kenny, I Scher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
The asymmetry in idiotype-isotype expression in the response to phosphocholine is due to divergence in the expressed repertoires of Lyb-5+ and Lyb-5- B cellsL S Wicker, G Guelde, I Scher, et al.
The Journal of Experimental Medicine|November 1, 1980
Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defectH S Boswell, M I Nerenberg, I Scher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Regulation of T15 idiotype dominance. II. Genes unlinked to the Igh locus regulate T15 dominance of the secondary adoptive transfer response to phosphocholineL S Wicker, G Guelde, I Scher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
The immune response to a synthetic amino acid terpolymer in man: relationship to HL-A typeI Scher, A K Berning, D M Strong, et al.
Nature Reviews. Clinical Oncology|March 6, 2013
Validation and clinical utility of prostate cancer biomarkersHoward I Scher, Michael J Morris, Steven Larson, et al.
Cancer Treatment Reports|May 1, 1986
Phase II trial of N-methylformamide for advanced renal cell carcinomaC N Sternberg, A Yagoda, H I Scher, et al.
Urology|April 1, 1995
Distinguishing prognostic and treatment-predictive information for localized prostate cancerG Steineck, J Adolfsson, H I Scher, et al.
Pageof 83